AI assistant
AGIOS PHARMACEUTICALS, INC. — Director's Dealing 2013
Jul 23, 2013
31580_dirs_2013-07-23_b20602a9-d239-4959-bf15-8095ae3556b9.zip
Director's Dealing
Open in viewerOpens in your device viewer
SEC Form 3 — Initial Statement of Beneficial Ownership
Issuer: AGIOS PHARMACEUTICALS INC (AGIO)
CIK: 0001439222
Period of Report: 2013-07-23
Reporting Person: Higgons John Duncan (Chief Operating Officer, 10% Owner)
Holdings (Non-Derivative)
| Security | Shares | Ownership |
|---|---|---|
| Common Stock | 109090 | Direct |
Holdings (Derivative)
| Security | Exercise Price | Expiration | Underlying | Shares | Ownership |
|---|---|---|---|---|---|
| Stock Option (right to buy) | $0.31 | 2019-08-12 | Common Stock (238769) | Direct | |
| Stock Option (right to buy) | $0.31 | 2019-08-12 | Common Stock (45454) | Direct | |
| Stock Option (right to buy) | $0.31 | 2020-03-25 | Common Stock (36363) | Direct | |
| Stock Option (right to buy) | $0.47 | 2021-03-01 | Common Stock (10909) | Direct | |
| Stock Option (right to buy) | $0.47 | 2021-03-01 | Common Stock (3636) | Direct | |
| Stock Option (right to buy) | $2.34 | 2022-04-05 | Common Stock (15909) | Direct |
Footnotes
F1: Reflects a 1-for-2.75 reverse stock split effected on July 11, 2013.
F2: This option was granted on August 13, 2009. The shares underlying this option vest as to 25% of the shares on May 18, 2010, with the remaining 75% vesting in 36 equal monthly installments thereafter.
F3: This option was granted on August 13, 2009 and is fully vested.
F4: This option was granted on March 26, 2010 and is fully vested.
F5: This option was granted on March 2, 2011. The shares underlying this option vest as to 25% of the shares on January 31, 2012, with the remaining 75% vesting in 36 equal monthly installments thereafter.
F6: This option was granted on March 2, 2011. The shares underlying this option vested as to 25% of the shares on the date of grant and as to 25% of the shares upon the achievement of a performance milestone on July 19, 2013. The remaining 50% of the shares underlying the option vest in equal monthly installments through July 19, 2015.
F7: This option was granted on April 6, 2012 for the purchase of 63,636 shares of common stock. The option vests as to 25% upon the achievement of a performance milestone, as to an additional 50% upon the achievement of a second performance milestone, and as to the remaining 25% on the first anniversary of the first date that both performance milestones were achieved. The performance criteria for the first performance milestone were met on March 18, 2013, resulting in the vesting of the option as to 15,909 shares.